Russia reports world's first case of human infection with H5N8 bird flu
>> Reuters
Published: 20 Feb 2021 06:44 PM BdST Updated: 20 Feb 2021 09:05 PM BdST
-
Chickens await vaccination against bird flu at the settlement Peredovoi 100 km (62 miles) from the Russia's southern city of Stavropol, March 11, 2006. Reuters
Russia has registered the first case of a strain of bird flu virus named A(H5N8) being passed to humans from birds and has reported the matter to the World Health Organization (WHO), Anna Popova, head of consumer health watchdog Rospotrebnadzor, said on Saturday.
Outbreaks of the H5N8 strain have been reported in Russia, Europe, China, the Middle East and North Africa in recent months but only in poultry. Other strains - H5N1, H7N9 and H9N2 - have been known to spread to humans.
Russia reported the case of human infection to the WHO "several days ago, just as we became absolutely certain of our results," Popova said on Rossiya 24 state TV. There was no sign of transmission between humans so far, she added.
The majority of human bird flu infections have been associated with direct contact with infected live or dead poultry, though properly cooked food is considered to be safe.
Bird flu outbreaks often prompt poultry plants to kill their birds to prevent the virus from spreading, and avoid importing countries having to impose trade restrictions.
The vast majority of cases are spread by migrating wild birds, so producing countries tend to keep their poultry indoors or protected from contact with wildlife.
Seven workers at a poultry plant in Russia's south had been infected with the H5N8 strain when there was an outbreak at the plant in December, Popova said, adding that the individuals involved felt fine now.
"This situation did not develop further," she added.
Siberia's Vector Institute said on Saturday it would start developing human tests and a vaccine against H5N8, RIA news agency reported.
The WHO did not reply to a Reuters request for comment.
-
Popular drug doesn't alleviate mild COVID symptoms: study
-
Study indicates Oxford vaccine effective against Brazil variant
-
SII warns of supply hit from US raw materials export ban
-
COVID drug causes quick reduction in virus: Merck
-
Doubling masks offers little help preventing viral spread
-
Why J&J's one-shot vaccine could be a game changer
-
Obesity a driving factor in COVID deaths: study
-
Delayed skin reactions reported to a COVID vaccine
-
Popular drug does not alleviate mild COVID-19 symptoms, study finds
-
Merck says study shows COVID-19 drug causes quick reduction in virus
-
Oxford study indicates AstraZeneca vaccine effective against Brazil variant
-
Indian vaccine giant SII warns of supply hit from U.S. raw materials export ban
-
Japan supercomputer shows doubling masks offers little help preventing viral spread
-
One and done: Why people are eager for Johnson & Johnson’s vaccine
Most Read
- Kawasaki ships first Dhaka Metrorail cars to Bangladesh
- Shishir set to become first transgender to present news on TV in Bangladesh
- Hasina named among top three 'inspirational' women leaders in Commonwealth
- How to register for coronavirus vaccine in Bangladesh
- Government not considering amendment to Digital Security Act: law minister
- Pakistani PM wins vote of confidence amidst opposition protest, boycott
- Bangladesh reports 10 new virus deaths, cases near 550,000
- Bangladesh releases e-posters to mark Bangabandhu’s 7th March speech
- Bangladesh charges nine with attacking former US ambassador Bernicat’s car
- Penalised for plagiarism, DU teacher Samia says she has been framed